Author Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103<sup>+</sup> dendritic cell differentiation.
Where this comes from
- Record sourced from PubMed, PMID 30770835.
- Also identified by DOI 10.1038/s41467-019-08770-5 and PMC identifier 6377651.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The original version of this Article contained errors in the author affiliations. Qingnan Zhao, Xueqing Xia, Longfei Huo and Shulin Li were incorrectly associated with Beijing Institute for Brain Disorders, 100069, Beijing, China.This has now been corrected in both the PDF and HTML versions of the Article.